首頁 > 市場調查報告書 > 醫療設備

體外診斷人工智能診斷用人工智能

市場調查報告書

商品編碼

1789659

歐洲的AI支援醫療影像市場:2025年

Europe AI-assisted Medical Imaging Market

出版日期: 2025年08月13日 | 出版商:

Marketstrat, Inc. | 英文 88 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

報告元資料

地理覆蓋範圍 歐洲（德國、法國、英國、義大利、西班牙及其他地區）
影像模式 CT、MRI、X光/DR、超音波、PET/核子醫學
臨床領域 腫瘤科、神經內科/中風科、心臟科、呼吸科/肺科、MSK/骨科、綜合診斷
應用領域 早期檢測/分診、診斷準確性與分類、工作流程/效率、預後與治療、影像增強/劑量、分割/特徵提取、跨模態整合
收入來源 硬體（工廠資本支出提升）、軟體（企業訂閱的固定許可證）、服務（實施/驗證/支援）、雲端/按使用付費（按掃描付費）。
最終用途醫院、診斷影像中心、診所、遠距放射科、其他供應商

報告摘要

歐洲人工智慧輔助醫學影像市場：2025報告衡量並預測了德國、法國、英國、義大利、西班牙和其他歐洲國家在 CT、MRI、X 光/DR、超音波和 PET/核醫領域的人工智慧支出。我們按醫療模式、臨床領域、應用、收入來源、最終用戶組織和人工智慧技術，提供 2023-2024 年的實際結果和 2025-2032 年的預測，以及歐洲特定的 GTM 成長與成熟度、生態系統協作以及解決方案採用與成長框架。這份 88 頁的 Marketstrat™ Markintel™ Pulse 報告專注於歐洲醫學影像領域的人工智慧發展。區域框架——GTM 成長與成熟度（供應商視角）、生態系統協作矩陣以及解決方案採用與成長——將證據轉化為排序、合作和定價決策。針對德國、法國、英國、義大利、西班牙和其他歐洲國家的國家/地區章節，提供了 GTM 準備、定價契合度和分層客戶格局的見解。我們的方法將歐洲自上而下的支出模型與自下而上的附加率 x ASP 引擎（按醫療模式和國家/地區劃分）進行協調，並根據監管備案文件、經審計的財務數據、持牌專家演講和 RWE 進行加權。國家現狀：德國將在 2027 年前轉向模組化 SaaS；英國將優先考慮雲端/使用定價；法國將優先考慮整合和合規性；義大利將透過 PNRR 發展由 MR 驅動的 AI；西班牙有理由減少積壓；RoE 集群展現出強大的改造潛力。決策框架：GTM 的成長和成熟、生態系統協作以及解決方案的採用和發展——所有這些都在歐洲層面進行。

本報告的受眾

OEM 領導層（產品、區域總經理、策略）
AI 專業供應商與平台（創辦人、銷售主管、合作夥伴）
供應商網路（資訊長/首席醫療官、放射科主任、採購）
投資人與股票分析師（醫療技術/人機互動技術）
顧問公司（行銷、定價、盡職調查）

您提供哪些決策支援（目前/下一季）？

您為企業/平台交易捆綁哪些解決方案？為市場上市捆綁哪些解決方案？
以國家定價（期限或企業版；訂閱或基於使用量）
試點到規模化計畫與採購節奏和證據預期保持一致
按國家/地區劃分的合作夥伴路線（OEM 商店、PACS 市場、雲端交換）

歐洲關鍵數據：截至 2032 年的總和成長里程碑
按模式、臨床領域、應用、收入來源、最終用途和 AI 技術細分
國家章節（德國、法國、英國、義大利、西班牙和歐洲其他地區）
GTM 準備就緒雷達、國家/地區定價矩陣、按層級劃分的客戶格局和預測表
區域框架（歐洲層級）
- GTM 成長與成熟度 - 供應商地圖
- 生態系協作矩陣 (ECM)
- 解決方案採用與成長矩陣
方法論：雙視角模型（自上而下對齊，自下而上附著率 x 平均售價），證據加權，品質保證檢查

為何購買此脈搏報告

統一模型：跨模態、國家/地區、應用和收入來源對齊數據
證據加權：將監管、財務和訪談訊號與清晰的置信度權重結合
行動導向：框架將數據驅動到定序、合作和定價
比客製化研究更快：現已提供以歐洲為中心的研究範圍。

方法概述

雙視角架構：自上而下的歐洲支出錨定總額，以及自下而上的每種模式和國家/地區 x ASP 引擎規模的藥品說明書創建率
證據支柱：CE MDR/UKCA 備案、經審計的財務報表、持牌專家電話記錄、同儕審查或會議 RWE
品質保證：表格/圖表之間的數值一致性、記錄的來源路徑、複審員的編輯檢查

關於本 "脈搏報告"
範圍與細分
Marketstrat 的 "洞察到行動" 方法
雙視角架構
自上而下的市場漏斗（歐洲）
自下而上的連線速率流（歐洲）
按國家和細分市場建模
證據可靠性 - 密度與可靠性（歐洲）
本脈動報告所包含的區域框架
GTM 國家/地區工具
品質保證與治理
限制與緩解措施

第三部分 - 歐洲市場分析

市場概覽與分析
- 市場快照
- 結構性需求訊號
- 監理與融資格局（2024-2028）
- 市場區隔：2032（價值佔有率）
- 競爭熱圖(2024-2026)
- 執行手冊 (2024-2027)
- 行動導向建議
歐洲市場估值與預測 (2023-2032，百萬美元)
Markintel 成長成熟度矩陣 - 歐洲
Markintel 生態系協作矩陣 (ECM) - 歐洲
Markintel 解採用與成長矩陣 - 歐洲
AI 應用率 - 歐洲
GTM 概覽 - 歐洲

第四部分 - 德國市場

德國市場概覽
宏觀與流行病學
醫療體系與資金狀況
監理與證據路徑
競爭格局
策略要點與建議
德國市場（依臨床）區域
德國市場依模式劃分（2023-2032，百萬美元）
德國市場依收入來源劃分（2023-2032，百萬美元）
德國市場依臨床應用劃分（2023-2032，百萬美元）
德國市場依最終使用機構劃分（2023-2032，百萬美元）
德國市場依人工智慧技術劃分（2023-2032，百萬美元）
GTM 概覽 - 德國

第五部 - 法國市場

市場概要：法國
法國市場預估與預測（2023-2032）
GTM 概覽 - 法國

第六部分 - 英國市場

英國市場概覽
英國市場
英國市場預估與預測(2023-2032)
GTM 概覽 - 英國

第七部分 - 義大利市場

市場概覽與總結：義大利
義大利市場預測 (2023-2032)
GTM 概覽 - 義大利

第八部 - 西班牙市場

西班牙市場概況與總結
策略要點
西班牙市場評估與預測 (2023-2032)
GTM 概覽 - 西班牙

第九章 - 歐洲其他地區市場

市場概覽：歐洲其他地區
策略要點
歐洲醫學影像 AI 市場 (2023-2032)
GTM 概覽 - 歐洲其他地區歐洲

簡介目錄圖表

Product Code: MINTP-M01121

Report Metadata

Geographic scope: Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
Clinical areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General Diagnostic
Applications: Early detection/triage; diagnostic accuracy & classification; workflow/efficiency; prognosis & treatment; image enhancement/dose; segmentation/feature extraction; integration across modalities
Revenue streams: Hardware (factory attach CAPEX uplift), Software (fixed licenses incl. enterprise subscriptions), Service (implementation/validation/support), Cloud/Pay per Use (metered per scan)
End use: Hospitals, Imaging Centers, Clinics, Teleradiology, Other providers

Report Summary

The Europe - AI assisted Medical Imaging Pulse report sizes and forecasts AI spend across CT, MRI, X ray/DR, Ultrasound, and PET/Nuclear for DE, FR, UK, IT, ES, RoE. It provides 2023-24 actuals and a 2025-2032 forecasts by modality, clinical area, application, revenue stream, end use organization, and AI technology-plus GTM Growth & Maturity, Ecosystem Collaboration, and Solution Adoption & Growth frameworks tailored to Europe.

This 88 page Markintel(TM) Pulse report from Marketstrat(TM) delivers a Europe only view of AI in medical imaging. Regional frameworks-GTM Growth & Maturity (vendor view), Ecosystem Collaboration Matrix, and Solution Adoption & Growth-translate evidence into sequencing, partnering, and pricing decisions. Country chapters for Germany, France, the UK, Italy, Spain, and RoE include GTM readiness, pricing fit, and tiered customer landscapes. Methodology reconciles a top down Europe spend model with bottom up attach rate x ASP engines by modality and country, weighted by regulatory filings, audited financials, licensed expert transcripts, and RWE.

Country reality: Germany pivots to modular SaaS by 2027; UK favors cloud/usage pricing; France prioritizes integration & compliance; Italy grows MR led AI via PNRR; Spain's case is backlog reduction; RoE clusters show strong retrofit potential.

Decision ready frameworks: GTM Growth & Maturity, Ecosystem Collaboration, Solution Adoption & Growth-all Europe level.

Who should use this report:

OEM leadership (product, regional GMs, strategy)
Specialist AI vendors & platforms (founders, sales leaders, partnerships)
Provider networks (CIO/CMIO, radiology chairs, procurement)
Investors & equity analysts (MedTech/HCIT)
Consulting & advisory firms (GTM, pricing, diligence)

What decisions it supports (now/next quarter)

Which solutions to bundle for enterprise/platform deals vs list in marketplaces.
Pricing fit-term vs enterprise subscription vs usage based by country.
Pilot to scale plans tied to procurement cadence and evidence expectations.
Partner routes (OEM stores, PACS marketplaces, cloud exchanges) per country.

What's inside:

Europe key numbers: totals and growth milestones through 2032.
Breakdowns by modality, clinical area, application, revenue stream, end use, AI technology.
Country chapters (DE, FR, UK, IT, ES, RoE) with: GTM readiness radar, country pricing matrix, tiered customer landscape, and forecast tables.
Regional frameworks (Europe level):
- GTM Growth & Maturity - vendor map
- Ecosystem Collaboration Matrix (ECM)
- Solution Adoption & Growth Matrix
Methodology: dual lens model (top down reconciliation; bottom up attach rate x ASP), evidence weighting, QA checks.

Why buy this Pulse report:

One coherent model: numbers reconcile across modality, country, application, and revenue stream.
Evidence weighted: regulatory, financial and interview based signals are combined with clear confidence weights.
Action oriented: frameworks translate data into sequencing, partnering, and pricing moves.
Faster than a custom study: focused Europe scope you can use today.

Methods in brief:

Dual lens architecture: top down Europe spend anchors totals; bottom up attach rate x ASP engines size each modality and country.
Evidence pillars: CE MDR/UKCA filings, audited financials, licensed expert call transcripts, and peer reviewed or conference RWE.
QA: numeric parity across tables/figures; documented source trail; second reader editorial check.

SECTION 1 - EXECUTIVE SUMMARY

What this Pulse Covers
Key Numbers Snapshot (Europe)
What's Driving Europe's Curve
Where the Value Pools Form
Country Outlook-Six Different Routes to Scale
Near term Watchlist (Next 12-18 Months)
What to do now (Insights -> Action)
- OEMs
- Pure plays
- Providers & Networks
- Investors

SECTION 2 - RESEARCH METHODOLOGY

About this Pulse Report
Scope & Segmentation
Marketstrat's "Insights -> Action" Approach
Dual lens Architecture
Top down Market Funnel (Europe)
- How it Works in the Model
Bottom up Attach rate Flow (Europe)
What we model for Each Country and Segment
Evidence Confidence - Density vs Reliability (Europe)
- Reading the Bubbles
Regional Frameworks Included in this Pulse Report
GTM Country Tools
Quality Assurance & Governance
Limitations & Mitigations

SECTION 3 - EUROPEAN MARKET ANALYSIS

Market Overview & Analysis
- Market Snapshot
- Structural Demand Signals
- Regulatory & Funding Landscape (2024-2028)
- Market Segmentation 2032 (value share)
- Competitive Heat Map (2024-26)
- Execution Playbook (2024-2027)
- Action-Oriented Recommendations
European Market Estimates and Forecasts by Country (2023-2032, USD Mill)
- Five Forces Shaping Adoption
- Country Archetypes & What Sells
- Near term Adoption Runway (2024-27)
- Strategic Implications
- Regulatory Velocity by Company - Europe
Markintel Growth Maturity Matrix - Europe
- Landscape Snapshot
- Why the Quadrant Looks the Way it Does
- Key Competitive Dynamics
- Strategic Takeaways
- Bottom Line
- M&A Watchlist - Europe
- Competitive Dataset - Europe
- Growth & Maturity Highlights - Europe
Markintel Ecosystem Collaboration Matrix (ECM) - Europe
- Quadrant Commentary & European Illustrations
- Action Checklist
Markintel Solution Adoption & Growth Matrix - Europe
- Quadrant Deep Dive
- What Moves a Solution from One Box to the Next?
- Strategic Guidance
AI Attach Rate - Europe
- OEM AI Attach Rate
- Attach Rate Trends - Europe
- AI Revenue Split - Factory vs Retrofit Attach -- Europe
GTM at a Glance - Europe
- Channel & Pricing Matrix (2025-2028)
- GTM Readiness Radar - Europe
- Tiered Customer Landscape (2032 View)
- GTM Timeline (2025 -> 2028) - Europe
- Adjacency Opportunity Radar (2026+) - Europe
- Regulatory x Funding Heatmap - Europe
- AI Imaging Whitespace Matrix - Europe
- Fast Strategic Cues (2025 playbook)

SECTION 4 - GERMAN MARKET

Market Overview - Germany
Macro & Epidemiology
Health system & Funding Landscape
Regulatory & Evidence Pathway
Competitive Landscape
Strategic Takeaways & Recommendations
German Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- Primary Growth Catalysts
- Strategic Messages for Stakeholders
- Key Takeaways
German Market by Modality (2023-2032, USD Million)
- Forecast by Modality (2023-2032, USD Mill)
- Key Inflection by Modality
- What's Driving Each Modality
- Strategic Implications
German Market by Revenue Stream (2023-2032, USD Million)
- Forecast by Revenue Stream (2023-2032, USD Mill)
- Revenue Streams and Drivers
- Key Dynamics by Stream
- Strategic Guidance
German Market by Clinical Application (2023-2032, USD Million)
- Forecast by Clinical Application (2023-2032, USD Mill)
- What is Driving Each Bucket
- Strategic Messages
- Action Playbook
German Market by End-Use Organization (2023-2032, USD Million)
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Segments Review
- Strategic Implications
German Market by AI Technology (2023-2032, USD Million)
- Forecast by AI Technology (2023-2032, USD Mill)
- Germany - AI Imaging Market by Core Technology
- Why Deep Learning Keeps the Lion's Share
- Break-out Growth Themes
- Strategic Playbook
GTM at-a-Glance - Germany
- Channel x Pricing Matrix
- GTM Readiness Radar - Germany
- Tiered Customer Landscape
- GTM Timeline - Germany
- Fast Strategic Cues

SECTION 5 - FRENCH MARKET

Market Summary: France
- Top line Snapshot - France
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- French Market Speed scan - Market Analysis (2024-2032)
French Market Estimates and Forecasts (2023-2032)
- French Market by Clinical Area (2023-2032)
- French Market by Modality (2023-2032)
- French Market by Revenue Stream (2023-2032)
- French Market by Clinical Application (2023-2032)
- French Market by End-Use Organization (2023-2032)
- French Market by AI Technology (2023-2032)
GTM at a Glance - France
- Channel x Pricing Matrix
- GTM Readiness Radar - What Counts Most in France
- GTM Timeline (2024-30) - France
- Spend Potential by Customer Tier - France

SECTION 6 - UNITED KINGDOM MARKET

Market Overview - United Kingdom
UK Market Speed Scan
- Scale & growth
- Policy & funding
- Demand triggers
- Procurement routes
- Competitive Field
- Winning playbook 2024-27
UK Market Estimates and Forecasts (2023-2032)
- UK Market by Clinical Area (2023-2032)
- UK Market by Modality (2023-2032)
- UK Market by Revenue Stream (2023-2032)
- UK Market by Clinical Application (2023-2032)
- UK Market by End-Use Organization (2023-2032)
- UK Market by AI Technology (2023-2032)
GTM at a Glance - UK
- Channel x Pricing Matrix
- GTM Readiness Radar - UK
- Fast Strategic Cues
- Tiered Customer Landscape - UK
- GTM Timeline (2024-29) - UK

SECTION 7 - ITALIAN MARKET

Market Overview & Summary: Italy
- What Makes Italy Unique in the EU Context
- Strategic Takeaways
Italian Market Estimates & Forecasts (2023-2032)
- Italian Market by Clinical Area (2023-2032)
- Italian by Modality (2023-2032)
- Italian Market by Revenue Stream (2023-2032)
- Italian Market by Clinical Application (2023-2032)
- Italian Market by End-Use Organization (2023-2032)
- Italian Market by AI Technology (2023-2032)
GTM at a Glance - Italy
- Channel x Pricing Matrix
- Tiered Customer Landscape & Spend Potential (2032) - Italy
- GTM Readiness Radar - Italy
- GTM Timeline (2024-29) - Italy
- Fast Strategic Cues

SECTION 8 - SPANISH MARKET

Market Overview & Summary - Spain
Strategic Takeaways
Spanish Market Estimates and Forecasts (2023-2032)
- Spanish Market by Clinical Area (2023-2032)
- Spanish Market by Modality (2023-2032)
- Spanish Market by Clinical Application (2023-2032)
- Spanish Market by Revenue Stream (2023-2032)
- Spanish Market by End-Use Organization (2023-2032)
- Spanish Market by AI Technology (2023-2032)
GTM at a Glance - Spain
- GTM Readiness Radar - Spain
- Channel x Pricing Matrix
- Tiered Customer Landscape - Spain
- GTM Timeline - Spain

SECTION 9 -REST OF EUROPE (ROE) MARKET

Market Overview: Rest of Europe (ROE)
- Size & trajectory
- Why Growth Accelerates
- Risks / Headwinds
Strategic Takeaways
Rest of European Market for AI in Medical Imaging (2023-2032)
- Rest of European Market by Clinical Area (2023-2032)
- Rest of European Market by Modality (2023-2032)
- Rest of European Market by Revenue Stream (2023-2032)
- Rest of European Market by Clinical Application (2023-2032)
- Rest of European Market by End-Use Organization (2023-2032)
- Rest of European Market by AI Technology (2023-2032)
GTM at a Glance - Rest of Europe (ROE)
- GTM Readiness Radar - ROE
- Tiered Customer Landscape - ROE
- GTM Timeline - ROE
- Channel x Pricing Matrix
- Adjacency-Opportunity Matrix (2026-2030)
- Country-Cluster Framework & Strategic Playbook
- White-Space Partnership Matrix
- Regulatory Funding Heatmap (ROE Clusters)
- Fast Strategic Cues

簡介目錄圖表

List of Tables

Table 1: AI Imaging Market by Country - Europe (2023-2032, USD Mill)
Table 2: German Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 3: German Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 4: German Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 5: German Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 6: German Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 7: German Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 8: French Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 9: French Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 10: French Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 11: French Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 12: French Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 13: French Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 14: UK Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 15: UK Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 16: UK Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 17: UK Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 18: UK Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 19: UK Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 20: Italian Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 21: Italian Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 22: Italian Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 23: Italian Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 24: Italian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 25: Italian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 26: GTM Readiness Radar - Italy
Table 27: Spanish Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 28: Spanish Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 29: Spanish Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 30: Spanish Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 31: Spanish Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 32: Spanish Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 33: Rest of Europe Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
Table 34: Rest of Europe Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
Table 35: Rest of Europe Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
Table 36: Rest of Europe Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
Table 37: Rest of Europe Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
Table 38: Rest of Europe Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
Table 39: Adjacency-Opportunity Matrix - ROE (2026-2030)
Table 40: White-Space Partnership Matrix - ROE